Dr. Roopesh Singh Gangwar, PhD - Case Western Reserve University - Postdoc scholar

Dr. Roopesh Singh Gangwar

PhD

Case Western Reserve University

Postdoc scholar

Cleveland, OH | United States

ORCID logohttps://orcid.org/0000-0002-3171-5952

Dr. Roopesh Singh Gangwar, PhD - Case Western Reserve University - Postdoc scholar

Dr. Roopesh Singh Gangwar

PhD

Introduction

Primary Affiliation: Case Western Reserve University - Cleveland, OH , United States

Education

Sep 2005 - Aug 2012
National Institute of Virology, University of Pune
Ph.D
Encephalitis Group
Aug 2004 - Aug 2005
The Maharaja Sayajirao University of Baroda
Post M.Sc.Diploma in Genetic Engineering and Bioprocesses Development
Department of Microbiology and Biotechnology Centre
Jan 2001 - Jan 2003
Chhatrapati Shahu Ji Maharaj University
M.Sc.
Biotechnology

Experience

Jan 2017 - Jan 2017
Case Western Reserve University School of Medicine
Postdoctoral Research Scholar
Cardiology
Jun 2012 - Jun 2012
Institute for Drug Research, The Hebrew University of Jerusalem
Postdoctoral Fellow
Pharmacology and Experimental Therapeutics

Publications

15Publications

64Reads

507Profile Views

31PubMed Central Citations

CD300a expression is modulated in atopic dermatitis and could influence the inflammatory response.

Allergy 2019 Jan 22. Epub 2019 Jan 22.

Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Faculty of Medicine, Institute for Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/all.13724DOI Listing
January 2019
2 Reads
6.028 Impact Factor

Evaluation of Soluble CD48 Levels in Patients with Allergic and Nonallergic Asthma in Relation to Markers of Type 2 and Non-Type 2 Immunity: An Observational Study.

J Immunol Res 2018 16;2018:4236263. Epub 2018 Sep 16.

Pharmacology and Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/4236263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165012PMC
December 2018
1 Read

Leukocyte CD300a Contributes to the Resolution of Murine Allergic Inflammation.

J Immunol 2018 Nov 12;201(10):2998-3005. Epub 2018 Oct 12.

Pharmacology and Experimental Therapeutics Unit, School of Pharmacy, Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91120, Israel; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1801000DOI Listing
November 2018
2 Reads
4.922 Impact Factor

Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.

Am J Hypertens 2018 Jan;31(2):150-165

Cardiovascular Research Institute (CVRI), Case Western Reserve University, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpx197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861558PMC
January 2018
9 Reads
4 Citations
2.852 Impact Factor

CD48 on blood leukocytes and in serum of asthma patients varies with severity.

Allergy 2017 06 1;72(6):888-895. Epub 2016 Dec 1.

Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/all.13082DOI Listing
June 2017
5 Reads
4 Citations
6.030 Impact Factor

Mast cell and eosinophil surface receptors as targets for anti-allergic therapy.

Pharmacol Ther 2017 02 20;170:37-63. Epub 2016 Oct 20.

Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2016.10.010DOI Listing
February 2017
11 Reads
4 Citations
9.723 Impact Factor

Mast cells and eosinophils in allergy: Close friends or just neighbors.

Eur J Pharmacol 2016 May 23;778:77-83. Epub 2015 Oct 23.

Department of Pharmacology and Experimental Therapeutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, POB 12065, Jerusalem 91120, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2015.10.036DOI Listing
May 2016
2 Reads
1 Citation
2.532 Impact Factor

Mast cells' integrated actions with eosinophils and fibroblasts in allergic inflammation: implications for therapy.

Adv Immunol 2015 2;125:41-85. Epub 2015 Jan 2.

Department of Pharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.ai.2014.09.002DOI Listing
July 2015
6 Reads
6 Citations
5.962 Impact Factor

Eosinophils interaction with mast cells: the allergic effector unit.

Methods Mol Biol 2014 ;1178:231-49

Department of Pharmacology and Experimental Therapeutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, 12065, Jerusalem, 91120, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-1016-8_20DOI Listing
February 2015
6 Reads
2 Citations

Author response to 'Staphylococcus aureus and primary lysis of eosinophils' by Dr Persson.

Clin Exp Allergy 2015 Feb;45(2):490-1

Pharmacology & Experimental Therapeutics, Faculty of Medicine, Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cea.12479DOI Listing
February 2015
1 Read
4.770 Impact Factor

Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation.

J Invest Dermatol 2014 Dec 7;134(12):2928-2937. Epub 2014 Jul 7.

Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2014.280DOI Listing
December 2014
9 Reads
4 Citations
7.220 Impact Factor

The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation.

Clin Exp Allergy 2014 Nov;44(11):1335-46

Pharmacology & Experimental Therapeutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cea.12422DOI Listing
November 2014
3 Reads
3 Citations
4.770 Impact Factor

Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes.

Virus Res 2012 Jan 27;163(1):40-50. Epub 2011 Aug 27.

Encephalitis Group, National Institute of Virology, Sus Road Campus, 130/1, Pashan, Pune 411021, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virusres.2011.08.008DOI Listing
January 2012
1 Read
1 Citation
2.324 Impact Factor

Delineation of an epitope on domain I of Japanese encephalitis virus Envelope glycoprotein using monoclonal antibodies.

Virus Res 2011 Jun 6;158(1-2):179-87. Epub 2011 Apr 6.

Japanese Encephalitis Group, National Institute of Virology, Sus Road Campus, 130/1, Pashan, Pune 411021, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virusres.2011.03.030DOI Listing
June 2011
2 Reads
2 Citations
2.324 Impact Factor

Top co-authors

Francesca Levi-Schaffer
Francesca Levi-Schaffer

School of Pharmacy

8
Nadine Landolina
Nadine Landolina

Institute for Drug Research

3
Roopesh Singh Gangwar
Roopesh Singh Gangwar

Case Western Reserve University

3
Laila Karra
Laila Karra

Institute for Drug Research

2
Sanjay Rajagopalan
Sanjay Rajagopalan

The Ohio State University

2
Harri Alenius
Harri Alenius

Finnish Institute of Occupational Health

2
Nanna Fyhrquist
Nanna Fyhrquist

Finnish Institute of Occupational Health

2
Milind M Gore
Milind M Gore

National Institute of Virology

2
Pratip Shil
Pratip Shil

National Institute of Virology

2